Point72 Hong Kong LTD Spectrum Pharmaceuticals Inc Transaction History

Point72 Hong Kong LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.7 - $1.4 $571 - $1,143	817 New	817 $1,000
Q1 2022 May 16, 2022	SELL	$0.63 - $1.59 $10,553 - $26,635	-16,752 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.27 - $2.42 $21,275 - $40,539	16,752 New	16,752 $21,000
Q3 2021 Nov 15, 2021	SELL	$2.15 - $3.82 $8,073 - $14,344	-3,755 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.89 - $4.45 $8,138 - $12,531	2,816 Added 299.89%	3,755 $14,000
Q1 2021 May 17, 2021	BUY	$2.9 - $4.09 $2,723 - $3,840	939 New	939 $3,000
Q1 2020 May 15, 2020	SELL	$1.83 - $3.45 $7,239 - $13,648	-3,956 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $11,116 - $32,871	3,176 Added 407.18%	3,956 $14,000
Q3 2019 Nov 14, 2019	BUY	$7.03 - $9.7 $5,483 - $7,565	780 New	780 $6,000
Q2 2019 Aug 14, 2019	SELL	$7.36 - $11.26 $3,208 - $4,909	-436 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$9.08 - $11.84 $3,958 - $5,162	436 New	436 $5,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.